We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The most recent scientific research on exposure to electric and magnetic fields.
Information about mercury, for use in responding to chemical incidents.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Information on asbestos, for use in responding to chemical incidents.
Reports and statements from the Committee on the Medical Effects of Air Pollutants (COMEAP).
Check what you need to do to sell cosmetic products in Great Britain.
Immediate and long term health effects of explosions and exposure to chemicals that occur during an explosion or fire.
Forms for the notification of serious undesirable effects (SUEs) from cosmetic products in Great Britain.
COMEAP statement on the evidence of health effects from exposure to nitrogen dioxide.
Information on how to report a serious undesirable effect (SUE) or safeguarding issue for cosmetic products.
Systematic review of the evidence around the health effects associated with exposure to setae of OPM larvae and a summary of the findings.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
How to account for VAT on goods and services provided by registered health professionals, including doctors, dentists, nurses and pharmacists.
Information on benzo(a)pyrene (BaP), an indicator species for polycyclic aromatic hydrocarbons (PAHs), for use in responding to chemical incidents.
Information on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a dioxin compound, for use in responding to chemical incidents.
Information on toluene diisocyanate, for use in responding to chemical incidents.
Healthcare professionals prescribing fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin) are reminded to be alert to the risk of disabling and potentially long-lasting or irreversible side effects. Do not prescribe fluoroquinolones for non-severe or self-limiting infections, or for mild to...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).